Market Size, Competition Pattern and Future Development Forecast of China Animal Vaccine Market

Since 2003, with the rapid development of livestock and poultry breeding industry and the implementation of compulsory immunization policy for major animal diseases, China’s market size of animal vaccine has seen rapid growth, the sales value of domestic and foreign manufacturers has increased to 1.4 billion yuan in 2015 from about 3 million yuan, reaching a compound growth rate of 15.1%, of which,hog and poultry vaccine accounted for 81.4% of total sales value.

Chapter One Development Course and Policy Environment of China’s Animal Vaccine Industry

1.1 Development course of China’s animal vaccine industry
1.2 Position and share of animal vaccine in China’s animal health product industry
1.3 Comparison between global and Chinese animal vaccine industry
1.4 Policy environment of China’s animal vaccine industry
1.4.1“National Mid-and-long Term Plan for Animal Diseases Control”
1.4.2 China’s production policy for animal vaccine industry
1.4.3 Influence of compulsory immunization policy adjustment on China’s animal vaccine industry
1.4.4 China’s circulation policy for animal vaccine industry
1.4.5 China’s trade policy for animal vaccine industry
1.5 Development direction of China’s animal vaccine industry
 
Chapter Two China’s Market Size of Animal Vaccine Industry in 2015
2.1 China’s market size of animal vaccine market
2.1.1 Market size of domestic vaccine
2.1.2Market size of foreign vaccine
2.2 China’s Market size of swine vaccine
2.2.1 China swine diseases epidemic situation analysis
2.2.2China’s market size of swine vaccine
2.2.3Market size of main swine vaccines
2.2.3.1 Market size and product features of FMD vaccine
2.2.3.2Market size and product features of CSF vaccine
2.2.3.3Market size and product features of PRRS vaccine
2.2.3.4Market size and product features of PRV vaccine
2.2.3.5Market size and product features of PCV2 vaccine
2.2.3.6Market size of other vaccines
2.2.4 Market concentration of top 10 swine vaccine enterprises in China
2.3 China’s market size of poultry vaccine
2.3.1 China poultry diseases epidemic situation analysis
2.3.2 China’s market size of poultry vaccine
2.3.3 Market size of main poultry vaccines
2.3.3.1 Market size and product features of H5N1 vaccine
2.3.3.2 Market size and product features of ND vaccine
2.3.3.3 Market size and product features of MD vaccine
2.3.3.4 Market size and product features of IBD vaccine
2.3.3.5 Market size and product features of IB vaccine
2.3.3.6 Market size of other vaccines
2.3.4 Market concentration of top 10 poultry vaccine enterprises in China
2.4 China’s market size of ruminant vaccine
2.4.1 China’s ruminant diseases epidemic situation analysis
2.4.2 China’s market size of ruminant vaccine
2.4.3 Market size of main ruminant vaccines
2.4.3.1 Market size and product features of FMD vaccine
2.4.3.2Market size and product features of brucellosis vaccine
2.4.3.3Market size and product features of PPR vaccine
2.4.3.4Market size of other vaccines
2.4.4 Market concentration of ruminant vaccine industry in China
2.5 China’s market size of other animal vaccines
 
Chapter Three Development Trend of China’s Animal Vaccine Industry
3.1 Change trend of swine vaccine market size
3.1.1 Vaccine expense analysis of pig farms of different sizes
3.1.2 China’s breeding quantity of pigs in next decade
3.1.3 China’s scale level of pig breeding in next decade
3.1.4 Forecast on growth of market size of swine vaccine in next decade
3.2 Change trend of poultry vaccine market size
3.2.1 Vaccine expense analysis of chicken farms of different sizes
3.2.2 China’s breeding quantity of poultry in next decade
3.2.3 China’s scale level of poultry breeding in next decade
3.2.4 Forecast on growth of market size of poultry vaccine in next decade
3.3 Change trend of market size of other vaccines
3.3.1 Forecast on growth of market size of ruminant vaccine in next decade
3.3.2 Forecast on growth of market size of aquatic vaccine in next decade
3.3.3 Forecast on growth of market size of pet vaccine in next decade
 
Chapter Four Analysis of Industrial Chain of China’s Animal Vaccine Industry
4.1 R&D link
4.1.1Main research institutions of China’s animal vaccine industry
4.1.2Technology research and development mode of China’s animal vaccine industry
4.1.3 Technology research and development capacity of China’s animal vaccine industry
4.1.4 Summary of technology transfer of China’s main animal vaccines (research unit, transfer price and acceptor)
4.2 Production link
4.2.1 Number of animal vaccine enterprises in China
4.2.2Capacity and output value of animal vaccine enterprises in China
4.2.3Analysis of gross profit rate of China’s animal vaccine industry
4.2.4Price analysis of China’s main animal vaccine products
4.2.5Analysis of market concentration of China’s animal vaccine industry
4.3 Circulation link
4.3.1 Circulation ways of animal vaccine in China
4.3.2 Analysis of distribution channel of animal vaccine in China
4.3.3 Analysis of profit of animal vaccine dealers in China
4.3.4Change trend of distribution channel of animal vaccine in China
 
Chapter Five Analysis of Main Animal Vaccine Enterprises in China
5.1 CAHIC
5.1.1 Company profile
5.1.2 Vaccine product mix
5.1.3 Animal vaccine sales revenue
5.1.4 Forecast on performance growth in next five years
5.2 JINYU BIO-TECHNOLOGY CO., LTD.
5.2.1 Company profile
5.2.2 Vaccine product mix
5.2.3 Animal vaccine sales revenue
5.2.4 Forecast on performance growth in next five years
5.3 PULIKE
5.3.1 Company profile
5.3.2 Vaccine product mix
5.3.3 Animal vaccine sales revenue
5.3.4 Forecast on performance growth in next five years
5.4 HILE
5.4.1 Company profile
5.4.2 Vaccine product mix
5.4.3 Animal vaccine sales revenue
5.4.4 Forecast on performance growth in next five years
5.5 Tianjin Ringpu
5.5.1 Company profile
5.5.2 Vaccine product mix
5.5.3 Animal vaccine sales revenue
5.5.4 Forecast on performance growth in next five years
5.6 CHOPPER
5.6.1 Company profile
5.6.2 Vaccine product mix
5.6.3 Animal vaccine sales revenue
5.6.4 Forecast on performance growth in next five years
5.7 TECON
5.7.1 Company profile
5.7.2 Vaccine product mix
5.7.3 Animal vaccine sales revenue
5.7.4 Forecast on performance growth in next five years
5.8 WINSUN
5.8.1 Company profile
5.8.2 Vaccine product mix
5.8.3 Animal vaccine sales revenue
5.8.4 Forecast on performance growth in next five years
5.9 CHINA AGRICULTURAL VET.BIO.SCIENCE and TECHNOLOGY CO., LTD. 
5.9.1 Company profile
5.9.2 Vaccine product mix
5.9.3 Animal vaccine sales revenue
5.9.4 Forecast on performance growth in next five years
5.10JILIN ZHENGYE BIOLOGICAL CO., LTD.
5.10.1 Company profile
5.10.2 Vaccine product mix
5.10.3 Animal vaccine sales revenue
5.10.4 Forecast on performance growth in next five years
 
Chapter Six Analysis of Main Foreign Animal Vaccine Enterprises
6.1 BoehringerIngelheim
6.1.1 Company profile
6.1.2 Vaccine product mix
6.1.3 Animal vaccine sales revenue
6.1.4 Forecast on performance growth in next five years
6.2 ZOETIS
6.2.1 Company profile
6.2.2 Vaccine product mix
6.2.3 Animal vaccine sales revenue
6.2.4 Forecast on performance growth in next five years
6.3 Merial
6.3.1 Company profile
6.3.2 Vaccine product mix
6.3.3 Animal vaccine sales revenue
6.3.4 Forecast on performance growth in next five years
6.4 HIPRA
6.4.1 Company profile
6.4.2 Vaccine product mix
6.4.3 Animal vaccine sales revenue
6.4.4 Forecast on performance growth in next five years
6.5 MSD
6.5.1 Company profile
6.5.2 Vaccine product mix
6.5.3 Animal vaccine sales revenue
6.5.4 Forecast on performance growth in next five years